World's Best Scientists 2026 revealed!
Jean-Michel Azorin

Jean-Michel Azorin

Award Badge
Psychology
France
2026

D-Index & Metrics

Psychology

D-Index
64
Citations
15311
World Ranking
2976
National Ranking
12

Jean-Michel Azorin publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Jean-Michel Azorin sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 431 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Jean-Michel Azorin D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Michel Azorin sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 64 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Psychology in France Leader Award

Overview

Jean-Michel Azorin is affiliated with Aix-Marseille University in France. Their research primarily spans the field of Medicine, with a strong focus on Psychiatry and Mental Health, supported by additional work in Clinical Psychology, Experimental and Cognitive Psychology, Cognitive Neuroscience, and Biological Psychiatry.

Their scientific contributions cover major topics related to mood disorders and neuropsychiatric treatments, including:

  • Bipolar Disorder and Treatment
  • Schizophrenia research and treatment
  • Electroconvulsive Therapy Studies
  • Suicide and Self-Harm Studies
  • Mental Health Research Topics
  • Tryptophan and brain disorders
  • Functional Brain Connectivity Studies

Azorin has authored numerous papers that contribute to understanding mood disorders and their clinical implications. Significant recent publications include:

  • "Association between anhedonia and suicidal events in patients with mood disorders: A 3-year prospective study," 2020, published in Depression and Anxiety
  • "Symptom networks in acute depression across bipolar and major depressive disorders: A network analysis on a large, international, observational study," 2020, published in European Neuropsychopharmacology
  • "Allostatic load, emotional hyper-reactivity, and functioning in individuals with bipolar disorder," 2020, published in Bipolar Disorders
  • "Deconstructing major depressive episodes across unipolar and bipolar depression by severity and duration: a cross-diagnostic cluster analysis on a large, international, observational study," 2020, published in Translational Psychiatry
  • "The Impact of Bipolar Disorder on Couple Functioning: Implications for Care and Treatment. A Systematic Review," 2021, published in Medicina

The scientist frequently publishes in several specialized journals, which include:

  • Bipolar Disorders
  • Translational Psychiatry
  • Journal of Affective Disorders
  • CNS Spectrums
  • Expert Opinion on Drug Metabolism & Toxicology

Jean-Michel Azorin collaborates regularly with a network of coauthors, among whom the most frequent are:

  • Bruno Étain
  • V. Aubin
  • Marion Leboyer
  • Frank Bellivier
  • Raoul Belzeaux

Best Publications

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Systematic clinical methodology for validating bipolar-II disorder : data in mid-stream from a French national multi-site study (EPIDEP)

    Elie G Hantouche;Hagop S Akiskal;Sylvie Lancrenon;Jean-François Allilaire

  • Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

    Balance investigators;Geddes;G M Goodwin

  • Prevalence and Characteristics of Undiagnosed Bipolar Disorders in Patients With a Major Depressive Episode: The BRIDGE Study

    Jules Angst;Jean Michel Azorin;Charles L. Bowden;Giulio Perugi

  • Rates and correlates of employment in people with schizophrenia in the UK, France and Germany

    Steven Marwaha;Sonia Johnson;Paul Bebbington;Mai Stafford

  • International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder.

    Ayal Schaffer;Erkki T. Isometsä;Leonardo Tondo;Doris H Moreno

  • Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN)

    Hagop S Akiskal;Elie G Hantouche;Marc L Bourgeois;Jean-Michel Azorin

  • A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.

    Mauricio Tohen;Mauricio Tohen;Joseph F. Goldberg;Ana Maria Gonzalez-Pinto Arrillaga;Jean M. Azorin

  • Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode.

    Raoul Belzeaux;Aurélie Bergon;Valérie Jeanjean;Béatrice Loriod

  • Depression in schizophrenia: recognition and management in the USA

    Samuel G Siris;Donald Addington;Jean-Michel Azorin;Ian R.H Falloon

  • Burden on caregivers of people with schizophrenia: comparison between Germany and Britain

    Christiane Roick;Dirk Heider;Paul E Bebbington;Matthias C Angermeyer

  • Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II).

    Hagop S. Akiskal;Elie-Georges Hantouche;Jean François Allilaire;Daniel Sechter

  • A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.

    Jean-Michel Azorin;René Spiegel;Gary Remington;Jean-Marie Vanelle

  • Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.

    Ayal Schaffer;Erkki T Isometsä;Leonardo Tondo;Doris H Moreno

  • A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia?

    J Naudin;C Capo;B Giusano;J.L Mège

  • Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study

    Giulio Perugi;Jules Angst;Jean Michel Azorin;Charles L. Bowden

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder

    Heinz Grunze;Eduard Vieta;Guy M. Goodwin;Charles Bowden

  • Trait-related decision-making impairment in the three phases of bipolar disorder

    Marc Adida;Fabrice Jollant;Luke Clark;Nathalie Besnier

  • Relationship of suicide rates to economic variables in Europe: 2000-2011

    Konstantinos N. Fountoulakis;Wolfram Kawohl;Pavlos N. Theodorakis;Ad J.F.M. Kerkhof

  • Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.

    Olivier Blin;Jean Michel Azorin;Philippe Bouhours

  • Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis.

    Lance Smith;Victoria Cornelius;J M Azorin;G Perugi

Frequent Co-Authors

Eduard Vieta
Eduard Vieta University of Barcelona
Jules Angst
Jules Angst University of Zurich
Charles L. Bowden
Charles L. Bowden The University of Texas Health Science Center at San Antonio
Bruno Etain
Bruno Etain Université Paris Cité
Allan H. Young
Allan H. Young King's College London
Giulio Perugi
Giulio Perugi University of Pisa
Marion Leboyer
Marion Leboyer Paris-Est Créteil University
Philippe Courtet
Philippe Courtet University of Montpellier
Hagop S. Akiskal
Hagop S. Akiskal University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in psychology opens many doors, especially as demand for mental health professionals rises across the United States. Online psychology degrees now make it easier than ever to start your journey toward becoming a therapist, counselor, or mental health advocate. Programs typically cover foundational skills in counseling, research methods, and ethical practices.

One common career goal is licensure as a therapist, but requirements vary widely by location. For example, if you’re interested in becoming a licensed therapist in Anchorage, you'll need to fulfill specific educational and supervised clinical experience criteria. Meanwhile, the Arlington licensed therapist education requirements include completing an accredited graduate program and state-mandated exams.

Requirements can also differ in other cities—discover more about Atlanta licensed therapist education requirements and guidelines for how to become a licensed therapist in Aurora. No matter where you study, online degrees offer the flexibility to gain the credentials needed for diverse roles in the field of psychology.

Best Scientists Citing Jean-Michel Azorin

Trending Scientists

Recently Published Articles